Carol A. Ewanowich

Edmonton, AB, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

KAT6B/A::KANSL1 uterine sarcoma - A case with recurrences following uterine morcellation and the development of primary cell line model.

KAT6B/A::KANSL1 uterine sarcoma - A case with recurrences following uterine morcellation and the development of primary cell line model.

Journal: Gynecologic oncology reports

Published: June 01, 2026

Preclinical 3D model screening reveals digoxin as an effective therapy for a rare and aggressive type of endometrial cancer.

Preclinical 3D model screening reveals digoxin as an effective therapy for a rare and aggressive type of endometrial cancer.

Journal: Gynecologic oncology

Published: March 28, 2024

Cervical Adenocarcinoma: A Comparison of the Reproducibility of the World Health Organization 2003 and 2014 Classifications.

Cervical Adenocarcinoma: A Comparison of the Reproducibility of the World Health Organization 2003 and 2014 Classifications.

Journal: Journal of lower genital tract disease

Published: February 24, 2018

Interobserver Agreement in Endometrial Carcinoma Histotype Diagnosis Varies Depending on The Cancer Genome Atlas (TCGA)-based Molecular Subgroup.

Interobserver Agreement in Endometrial Carcinoma Histotype Diagnosis Varies Depending on The Cancer Genome Atlas (TCGA)-based Molecular Subgroup.

Journal: The American journal of surgical pathology

Published: January 13, 2017

An Immunohistochemical Algorithm for Ovarian Carcinoma Typing.

An Immunohistochemical Algorithm for Ovarian Carcinoma Typing.

Journal: International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists

Published: March 15, 2016

Targeted mutation analysis of endometrial clear cell carcinoma.

Targeted mutation analysis of endometrial clear cell carcinoma.

Journal: Histopathology

Published: September 11, 2014

Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study.

Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study.

Journal: British journal of cancer

Published: September 03, 2014

HNF-1β in ovarian carcinomas with serous and clear cell change.

HNF-1β in ovarian carcinomas with serous and clear cell change.

Journal: International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists

Published: September 28, 2013

Reproducibility of histological cell type in high-grade endometrial carcinoma.

Reproducibility of histological cell type in high-grade endometrial carcinoma.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: December 18, 2012

Showing 1-9 of 9

Last Updated: 09/26/2026